Regulus Therapeutics Inc.
RGLSDelisted Jun 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001505512
Regulus Therapeutics Inc. was delisted on Jun 25, 2025; its insiders filed their last Form 4 on Jun 27, 2025; 75 institutions reported holding it in 13F filings for Q1 2025, worth $107.0M in total; no superinvestor held it.
Q4 2024 vs. Q3 2024
How the institutions holding Regulus Therapeutics Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 70 | 1 | 69 | 0 |
| Shares | 56.7M | 60.0K | 53.5M | −3.16M (−5.6%) |
| Value | $89.1M | $94.2K | $84.5M | −$4.44M (−5.0%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Regulus Therapeutics Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Velan Capital Investment Management LP | 70,000 | $110.6K | 0.10% |
| PEAK6 LLC | 60,000 | $94.8K | 0.00% |
| Susquehanna International Group, LLP | 36,188 | $57.2K | 0.00% |
| Intech Investment Management LLC | 28,480 | $45.0K | 0.00% |
| Police & Firemen's Retirement System of New Jersey | 12,696 | $20.1K | 0.00% |
| BNP Paribas Arbitrage, SA | 7,151 | $11.3K | 0.00% |
| Nisa Investment Advisors, LLC | 760 | $1.20K | 0.00% |
| Russell Investments Group, Ltd. | 458 | $724 | 0.00% |
| SBI Securities Co., Ltd. | 412 | $651 | 0.00% |
| EverSource Wealth Advisors, LLC | 82 | $130 | 0.00% |
| Accredited Wealth Management, LLC | 2 | $4 | 0.00% |
Sold out (11)
Institutions that held Regulus Therapeutics Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Woodline Partners LP | 948,702 | $1.49M |
| Opaleye Management Inc. | 535,000 | $840.0K |
| TD Asset Management Inc | 302,000 | $486.2K |
| Sarissa Capital Management LP | 185,183 | $290.7K |
| Monashee Investment Management LLC | 147,049 | $230.9K |
| Manufacturers Life Insurance Company, The | 129,700 | $203.6K |
| American Century Companies Inc | 38,681 | $60.7K |
| AQR Capital Management LLC | 30,209 | $47.4K |
| Jane Street Group, LLC | 29,580 | $46.4K |
| HSBC Holdings PLC | 19,224 | $29.7K |
| Grimes & Company, Inc. | 10,975 | $17.2K |
Not filed for Q4 2024 yet (1)
Institutions that held Regulus Therapeutics Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| PEAK6 Investments LLC | 60,000 | $94.2K |